Lugano, Switzerland, 10 February 2023 – The ESMO Gynaecological Cancers Congress 2023, the annual event dedicated to improving the practice of gynaecological cancers specialists worldwide, will provide an overview of the latest treatments as well as insights into the biology and biomarkers of ovarian, uterine, cervical and even rare gynaecological cancers.
The event will be held in person in Barcelona, Spain, and online, through a virtual platform, on 23-24 February 2023.
Impact of overall survival results of PARP inhibitor trials and how their heterogeneous results are (re)shaping the future of their application
Session: Special symposium: How to interpret overall survival data with PARP inhibitors
Strategies to overcome PARP inhibitors mechanisms of resistance in ovarian cancer for better patient outcomes
Session: Treatment of ovarian cancer in 2023
Novel approaches with antibody drug conjugates to overcome treatment resistance in cervical cancer and innovative techniques to increase cure and reduce toxicity
Sessions: Is cervical cancer still an orphan disease? and ADCs in gynaecological cancers
New clinical and translational data to optimise clinical decisions
Proffered Paper and Mini Oral sessions
Understanding the molecular profiles of endometrial cancer to foster personalised treatment strategies beyond immunotherapy
Session: Endometrial cancer
Individually rare, but collectively common: New insights on therapeutic options for rare gynaecological cancers
Session: Multidisciplinary tumour board: Rare cancers
The results of around 80 studies will be presented either as mini oral or posters, and published online as a supplement of Annals of Oncology. The abstract titles can be viewed through the online programme.
“Pandemomics: Challenging assumptions in gynecologic oncology” by Michael Bookman, 24 February 2023, 11:45-12:15 CET
ESMO welcomes media interested in obtaining information and reporting on cancer issues. Only through the official accreditation process with the media registration form, accredited media representatives will be able to access (both in person and virtually): scientific and educational sessions, poster area and e-posters, exhibition and industry satellite symposia, congress webcasts, embargoed material.
ESMO Press Office
Notes to Editors
Please make sure to use the official name of the meeting in your reports: ESMO Gynaecological Cancers Congress 2023
and the official congress hashtag: #ESMOGynae23
Follow the conversation on Twitter, LinkedIn, Instagram, Facebook
About the European Society for Medical Oncology (ESMO)
ESMO is the leading professional organisation for medical oncology. With more than 28,000 members representing oncology professionals from 160 countries worldwide, ESMO is the society of reference for oncology education and information. Driven by a shared determination to secure the best possible outcomes for patients, ESMO is committed to standing by those who care about cancer through addressing the diverse needs of #ONEoncologycommunity, offering #educationforLIFE, and advocating for #accessiblecancerCARE. Visit www.esmo.org